Literature DB >> 33628235

Mid-Epidemic Forecasts of COVID-19 Cases and Deaths: A Bivariate Model Applied to the UK.

Peter Congdon1.   

Abstract

BACKGROUND: The evolution of the COVID-19 epidemic has been accompanied by efforts to provide comparable international data on new cases and deaths. There is also accumulating evidence on the epidemiological parameters underlying COVID-19. Hence, there is potential for epidemic models providing mid-term forecasts of the epidemic trajectory using such information. The effectiveness of lockdown or lockdown relaxation can also be assessed by modelling later epidemic stages, possibly using a multiphase epidemic model.
METHODS: Commonly applied methods to analyse epidemic trajectories or make forecasts include phenomenological growth models (e.g., the Richards family of densities) and variants of the susceptible-infected-recovered (SIR) compartment model. Here, we focus on a practical forecasting approach, applied to interim UK COVID data, using a bivariate Reynolds model (for cases and deaths), with implementation based on Bayesian inference. We show the utility of informative priors in developing and estimating the model and compare error densities (Poisson-gamma, Poisson-lognormal, and Poisson-log-Student) for overdispersed data on new cases and deaths. We use cross validation to assess medium-term forecasts. We also consider the longer-term postlockdown epidemic profile to assess epidemic containment, using a two-phase model.
RESULTS: Fit to interim mid-epidemic data show better fit to training data and better cross-validation performance for a Poisson-log-Student model. Estimation of longer-term epidemic data after lockdown relaxation, characterised by protracted slow downturn and then upturn in cases, casts doubt on effective containment.
CONCLUSIONS: Many applications of phenomenological models have been to complete epidemics. However, evaluation of such models based simply on their fit to observed data may give only a partial picture, and cross validation against actual trends is also valuable. Similarly, it may be preferable to model incidence rather than cumulative data, although this raises questions about suitable error densities for modelling often erratic fluctuations. Hence, there may be utility in evaluating alternative error assumptions.
Copyright © 2021 Peter Congdon.

Entities:  

Year:  2021        PMID: 33628235      PMCID: PMC7881738          DOI: 10.1155/2021/8847116

Source DB:  PubMed          Journal:  Interdiscip Perspect Infect Dis        ISSN: 1687-708X


  35 in total

1.  Foot and mouth disease revisited: re-analysis using Bayesian spatial susceptible-infectious-removed models.

Authors:  Andrew B Lawson; Georgiana Onicescu; Caitlyn Ellerbe
Journal:  Spat Spatiotemporal Epidemiol       Date:  2011-07-19

2.  A unified approach to the Richards-model family for use in growth analyses: why we need only two model forms.

Authors:  Even Tjørve; Kathleen M C Tjørve
Journal:  J Theor Biol       Date:  2010-09-08       Impact factor: 2.691

3.  Testing species abundance models: a new bootstrap approach applied to Indo-Pacific coral reefs.

Authors:  Sean R Connolly; Maria Dornelas; David R Bellwood; Terence P Hughes
Journal:  Ecology       Date:  2009-11       Impact factor: 5.499

4.  Assessing the severity of COVID-19.

Authors:  André Ricardo Ribas Freitas; Marcelo Napimoga; Maria Rita Donalisio
Journal:  Epidemiol Serv Saude       Date:  2020-04-06

5.  Cholera modeling: challenges to quantitative analysis and predicting the impact of interventions.

Authors:  Yonatan H Grad; Joel C Miller; Marc Lipsitch
Journal:  Epidemiology       Date:  2012-07       Impact factor: 4.822

Review 6.  Mathematical models to characterize early epidemic growth: A review.

Authors:  Gerardo Chowell; Lisa Sattenspiel; Shweta Bansal; Cécile Viboud
Journal:  Phys Life Rev       Date:  2016-07-11       Impact factor: 11.025

7.  Getting less deadly?

Authors:  Adam Vaughan
Journal:  New Sci       Date:  2020-08-28       Impact factor: 0.319

8.  An interactive web-based dashboard to track COVID-19 in real time.

Authors:  Ensheng Dong; Hongru Du; Lauren Gardner
Journal:  Lancet Infect Dis       Date:  2020-02-19       Impact factor: 25.071

9.  Serial Interval of COVID-19 among Publicly Reported Confirmed Cases.

Authors:  Zhanwei Du; Xiaoke Xu; Ye Wu; Lin Wang; Benjamin J Cowling; Lauren Ancel Meyers
Journal:  Emerg Infect Dis       Date:  2020-06-17       Impact factor: 6.883

10.  Short-term Forecasts of the COVID-19 Epidemic in Guangdong and Zhejiang, China: February 13-23, 2020.

Authors:  Kimberlyn Roosa; Yiseul Lee; Ruiyan Luo; Alexander Kirpich; Richard Rothenberg; James M Hyman; Ping Yan; Gerardo Chowell
Journal:  J Clin Med       Date:  2020-02-22       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.